These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23597611)

  • 1. Coronary artery aneurysms after sirolimus-eluting stent implantation: multimodality imaging evaluation.
    Fujino Y; Attizzani GF; Nakamura S; Costa MA; Bezerra HG
    JACC Cardiovasc Interv; 2013 Apr; 6(4):423-4. PubMed ID: 23597611
    [No Abstract]   [Full Text] [Related]  

  • 2. Kounis syndrome manifesting as coronary aneurysm and very late coronary stent thrombosis.
    Hoshi T; Sato A; Akiyama D; Kawabe M; Hiraya D; Aonuma K
    JACC Cardiovasc Interv; 2014 Nov; 7(11):e173-6. PubMed ID: 25459048
    [No Abstract]   [Full Text] [Related]  

  • 3. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right coronary artery 'diverticulosis' 4 years after sirolimus-eluting stent implantation associated with very late stent thrombosis.
    Good RI; Kalra S; Lee TC
    Heart; 2013 Nov; 99(21):1627. PubMed ID: 23749781
    [No Abstract]   [Full Text] [Related]  

  • 5. Very late stent thrombosis 5 years after implantation of a sirolimus-eluting stent observed by angioscopy and optical coherence tomography.
    Ishihara T; Awata M; Fujita M; Watanabe T; Iida O; Ishida Y; Nanto S; Uematsu M
    JACC Cardiovasc Interv; 2013 May; 6(5):e28-30. PubMed ID: 23702022
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary artery aneurysms and late stent thrombosis after sirolimus-eluting stent placement.
    Cano-García M; Bullones-Ramírez JA; Muñoz-Jiménez LD; Sánchez-González C; Álvarez-Rubiera J; Urbano-Carrillo CA
    Coron Artery Dis; 2016 Jun; 27(4):337-40. PubMed ID: 27110646
    [No Abstract]   [Full Text] [Related]  

  • 7. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-stent thin-cap fibroatheroma after drug-eluting stent implantation: ex-vivo evaluation of optical coherence tomography and intracoronary angioscopy.
    Fujii K; Hao H; Imanaka T; Kawano T; Takayama T; Hirayama A; Yamada T; Ishibashi-Ueda H; Hirota S; Masuyama T
    JACC Cardiovasc Interv; 2014 Apr; 7(4):446-7. PubMed ID: 24656539
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronary artery aneurysm occurring very late after drug-eluting stent implantation.
    Okamura K; Suematsu Y; Morizumi S; Kawata M
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1068-70. PubMed ID: 25164132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-in-human evaluation of a sirolimus-eluting coronary stent on an integrated delivery system: the DIRECT study.
    Webster M; Harding S; McClean D; Jaffe W; Ormiston J; Aitken A; Watson T
    EuroIntervention; 2013 May; 9(1):46-53. PubMed ID: 23685294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
    Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
    Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.
    Laynez A; Sardi G; Hauville C; Barbash IM; Pakala R; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):759-65. PubMed ID: 22488756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary edema demonstrated by cardiovascular magnetic resonance in patients with peri-stent inflammation and aneurysm formation after treatment by drug-eluting stents.
    Holm NR; Kim WY; Maeng M; Thrysøe SA; Bøtker HE; Thuesen L; Høyer S; Tu S; Falk E; Lassen JF; Nielsen PH; Christiansen EH
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):352-4. PubMed ID: 23512782
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there a need for distal protection during native vessel percutaneous coronary intervention in patients with stable coronary artery disease?
    Hildebrandt HA; Kahlert P; Baars T; Kleinbongard P; Erbel R; Heusch G
    J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):170-2. PubMed ID: 23846674
    [No Abstract]   [Full Text] [Related]  

  • 18. Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents.
    Sharma R; Ruia AV; Mahant TS
    BMC Cardiovasc Disord; 2022 Feb; 22(1):60. PubMed ID: 35172738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography and intravascular ultrasound of double kissing crush coronary bifurcation stenting.
    McGeoch RJ; Tanaka K; Kotowycz MA; Bezerra HG; Džavík V
    EuroIntervention; 2014 Jul; 10(3):338. PubMed ID: 24862341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.